MedTrace Logo

Modulation of Gut Microbiota by Probiotic in Children

NCT06474234 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-06-25

No results posted yet for this study

Summary

This project aims to study the benefits of probiotics namely Bifidobacterium infantis YLGB-1496 in modulating gut microbiota of healthy children, among pre-school children in Malaysia \<7 years old.

Conditions

  • Generally Healthy

Interventions

DIETARY_SUPPLEMENT

Probiotic

Bifidobacterium infantis YLGB-1496 at 1x10 log CFU/day for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Intervention consists of daily administration of 2g of maltodextrin, administered daily for 12-weeks)

Sponsors & Collaborators

  • National University of Malaysia

    collaborator OTHER

  • Min-Tze LIONG

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-29
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06474234 on ClinicalTrials.gov